KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.107
-0.008 (-6.99%)
Apr 29, 2026, 11:20 AM EDT - Market open
KALA BIO Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | - | - | - | 3.89 | 11.24 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | -65.37% | 76.67% | Upgrade
|
| Cost of Revenue | - | - | - | 2.56 | 4.1 | Upgrade
|
| Gross Profit | - | - | - | 1.33 | 7.14 | Upgrade
|
| Selling, General & Admin | 23.63 | 18.34 | 20.57 | 65.04 | 105.06 | Upgrade
|
| Research & Development | 18.78 | 22.09 | 18.59 | 17.65 | 11.52 | Upgrade
|
| Operating Expenses | 42.41 | 40.43 | 39.15 | 82.69 | 116.58 | Upgrade
|
| Operating Income | -42.41 | -40.43 | -39.15 | -81.36 | -109.43 | Upgrade
|
| Interest Expense | -3.28 | -5.78 | -5.81 | -7.27 | -8.38 | Upgrade
|
| Interest & Investment Income | 1.14 | 2.06 | 2.71 | 0.66 | 0.1 | Upgrade
|
| Other Non Operating Income (Expenses) | 5.67 | 6.2 | 3.97 | -0.93 | - | Upgrade
|
| EBT Excluding Unusual Items | -38.87 | -37.96 | -38.29 | -88.88 | -117.71 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.55 | - | 4.2 | 47 | - | Upgrade
|
| Asset Writedown | -1.41 | - | -7.6 | - | - | Upgrade
|
| Other Unusual Items | 13.85 | -0.55 | -0.51 | -2.93 | 1.72 | Upgrade
|
| Pretax Income | -26.98 | -38.51 | -42.2 | -44.82 | -142.61 | Upgrade
|
| Net Income | -26.98 | -38.51 | -42.2 | -44.82 | -142.61 | Upgrade
|
| Net Income to Common | -26.98 | -38.51 | -42.2 | -44.82 | -142.61 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 4 | 2 | 2 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 4 | 2 | 2 | 1 | Upgrade
|
| Shares Change (YoY) | 114.65% | 56.09% | 59.94% | 15.50% | 25.67% | Upgrade
|
| EPS (Basic) | -3.31 | -10.15 | -17.35 | -29.48 | -108.32 | Upgrade
|
| EPS (Diluted) | -3.31 | -10.15 | -17.35 | -29.48 | -108.32 | Upgrade
|
| Free Cash Flow | -32.01 | -29.59 | -28.54 | -79.22 | -109.12 | Upgrade
|
| Free Cash Flow Per Share | -3.93 | -7.79 | -11.73 | -52.10 | -82.89 | Upgrade
|
| Gross Margin | - | - | - | 34.22% | 63.55% | Upgrade
|
| Operating Margin | - | - | - | -2090.34% | -973.60% | Upgrade
|
| Profit Margin | - | - | - | -1151.64% | -1268.73% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -2035.48% | -970.83% | Upgrade
|
| EBITDA | -42.09 | -40.18 | -38.85 | -80.82 | -108.46 | Upgrade
|
| D&A For EBITDA | 0.32 | 0.26 | 0.3 | 0.54 | 0.98 | Upgrade
|
| EBIT | -42.41 | -40.43 | -39.15 | -81.36 | -109.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.